A protein that inhibits surfactant in respiratory distress syndrome

Biology of the Neonate
M IkegamiD D Berry

Abstract

A protein that interferes with surfactant function is present in the airways and alveoli of infants with respiratory distress syndrome (RDS). This inhibitor is also found in serum and amniotic fluid and presumably appears in the alveoli because of the abnormal protein leak present in the lungs of infants with RDS. This protein has a molecular weight of about 110,000 and is resistant to boiling or lipid extraction. As measured by radioimmunoassay, the ratio of inhibitor to phosphatidylcholine decreased from 8.1 +/- 2.3 early in the course of RDS to 0.7 +/- 0.1 on the day of extubation. The value at extubation was the same as that measured for preterm infants without RDS. The inhibitor to phosphatidylcholine ratio in airway samples from infants with RDS correlated significantly with simultaneously recorded pO2/FiO2 ratios and the peak inspiratory pressures used to normalized pCO2 values. These results are consistent with the concept that the inhibitor contributes to surfactant dysfunction and thus the respiratory failure characteristic of RDS.

Citations

Nov 1, 1990·Indian Journal of Pediatrics·R Dhanireddy
Apr 1, 1989·Respiration Physiology·T KobayashiB Robertson
Feb 26, 2004·Paediatric Respiratory Reviews·Neil N Finer
Nov 1, 1987·The American Review of Respiratory Disease·A Jobe, M Ikegami
Dec 1, 1990·The American Review of Respiratory Disease·W J Lamm, R K Albert
Oct 1, 1993·The American Review of Respiratory Disease·M IkegamiA H Jobe
Jan 1, 1990·European Journal of Pediatrics·L GortnerE Weller
May 1, 1988·Experimental Lung Research·B Robertson, B Lachmann
Jun 1, 1993·Annals of Medicine·B Robertson
Aug 1, 1990·American Journal of Obstetrics and Gynecology·B L TaborS B Oetomo
Nov 1, 1988·Acta Anaesthesiologica Scandinavica·J J EnnemaT Curstedt
Dec 12, 2001·Respiratory Research·A GüntherW Seeger
Feb 1, 1990·Acta Paediatrica Japonica; Overseas Edition·A H Jobe
Apr 1, 1995·Pediatric Pulmonology·A GolanE S Shinwell
Jan 1, 1991·International Journal of Technology Assessment in Health Care·M HallmanT A Merritt
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K R Khubchandani, J M Snyder
Jun 1, 1992·Journal of Paediatrics and Child Health·P B Colditz, D J Henderson-Smart
Feb 1, 1996·Pediatric Research·R BruniF J Walther

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.